Lack of evidence raises questions on long-term PPI use

There is rising concern over the side effects of long-term proton pump inhibitor (PPI) use but limited evidence to warrant discontinuation, a literature review...

Call for pharmacist access to the MBS for Chronic Disease Management

Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense. After a...

Pharmacists in 2023: roles and remuneration

Better remuneration and career support are key to the future of pharmacists’ roles. The pharmacy profession provides a much broader range of health services...

Resistance movement: Pharmacy’s fight against antimicrobial resistance

Antimicrobial resistance (AMR) has been ranked as serious a threat to society as terrorism. With millions of lives at risk, and trillions in GDP...

Q&A: ‘I’m going overseas tomorrow . . . can you witness...

While pharmacists are now (very) familiar with rapid antigen tests (RATs) for COVID-19 testing, the practice of observed RATs for the purpose of international...

King of poisons or ‘magic bullet’?

A potent poison purportedly behind the death of a king, arsenic has also served numerous, less-sinister, medicinal purposes. In fact, the terms ‘magic bullet’ and...